|
|
|
|
|
|
|
|
|
03.09.26 - 19:45
|
What Makes Enovis (ENOV) a New Buy Stock (Zacks)
|
|
|
Enovis (ENOV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....
|
|
|
03.09.26 - 15:03
|
Avenzo Therapeutics Announces Appointment of Barbara Bodem and Elizabeth Mily to Board of Directors as Independent Directors (Business Wire)
|
|
|
SAN DIEGO--(BUSINESS WIRE)--Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced the appointment of Barbara Bodem and Elizabeth Mily to its board of directors.
“We are delighted to welcome Barbara and Elizabeth as independent directors to our board of directors,” said Athena Countouriotis, M.D., Chair, President, and CEO of Avenzo. “Their proven track records along with their combined deep financial and business development expertise across the life science industry will be invaluable as we continue to advance our pipeline of potentially differentiated oncology therapies. We look forward to benefiting from their insights and leadership as we enter the next phase of our company's growth.”
Ms. Bodem is an accomplished business leader and experienced board director with more than 30 years of experience across the healthcare industry. She currently serves on the boards of BioMarin Pharmaceutical, Enovis Corpora...
|
|
|
|
|
|
|
|
|
01.09.26 - 12:48
|
eCential Robotics Announces Binding Offer from Enovis (PR Newswire)
|
|
|
eCential Robotics platform to join Enovis' enabling technology portfolio. GRENOBLE, France and FRANKLIN, Tenn., Sept. 1, 2026 /PRNewswire/ -- eCential Robotics, a leading developer of enabling technologies and surgical robotics, today announced that Enovis™ Corporation (NYSE: ENOV) has......
|
|
|
18.08.26 - 13:06
|
Former President of DePuy Synthes U.S. Joins Peptilogics Board (Business Wire)
|
|
|
Tim Czartoski's appointment reinforces moving beyond the device in orthopedic surgery towards therapeutic treatment of device-related infectionsPITTSBURGH--(BUSINESS WIRE)--#Biopharma--Tim Czartoski, orthopedic executive and former president of DePuy Synthes U.S. and most recently president of U.S. Surgical and Global R&D at Enovis, has joined the Peptilogics board of directors. His background in leading large orthopedic device businesses, including successful launches of robotic technology platforms and one of the industry's most advanced knee systems, lends significant value to Peptilogics as it moves towards bringing meaningful innovation to market. Czartoski sees tremendous opportunity in therapeutic solutions that advance or complement current approaches to prosthetic joint infections (PJI) and medical device-related infections (MDRI), complications that have been addressed almost exclusively through device and surgical innovation for more than fifty years.
“Infection is the most significant, uns...
|
|
|
|
|
|
|
|
|
06.08.26 - 12:12
|
Enovis Announces Second Quarter 2026 Results (GlobeNewswire EN)
|
|
|
Dallas, TX, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the second quarter ended July 3, 2026. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET....
|
|
|
|
|
|
|
17.07.26 - 14:03
|
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th (GlobeNewswire EN)
|
|
|
Dallas, TX, July 17, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2026 financial results on Thursday, August 6th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at www.enovis.com....
|
|
|
|
|
|
|
|